Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NT-0249
Cat. No.:
OB0425LY-219
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
NT-0249 is a special active NLRP3 inhibitor with anti-inflammatory activity.
Synonyms:
NT0249; 2763617-39-4; 1-Methyl-4-({[(S)-perhydro-2-furyl]methyl}[3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)ureidosulfonyl]amino)pyrazole, sodium salt
CAS No.:
2763617-39-4
Compound CID:
162749589
Formula:
C22H28N5NaO4S
Formula Weight:
481.54
Specification
Target:
NOD-like receptor (NLR)
Pathway:
Immunology/Inflammation
Storage:
Storage at -20°C.
Applications:
NT-0249 has potential applications in research in the areas of anti-inflammatory, anti-obesity and anti-tumor.
